Tuberculosis and HIV interaction in sub-Saharan Africa: impact on patients and programmes; implications for policies (Q36207851)

12 August 2017

1 reference

title

Tuberculosis and HIV interaction in sub-Saharan Africa: impact on patients and programmes; implications for policies (English)

1 reference

12 August 2017

0 references

0 references

Dermot Maher

1

0 references

Anthony D Harries

series ordinal

2

object named as

Anthony Harries

1 reference

12 August 2017

Haileyesus Getahun

3

1 reference

12 August 2017

1 August 2005

1 reference

Tropical Medicine and International Health

12 August 2017

1 reference

12 August 2017

10

1 reference

12 August 2017

8

1 reference

12 August 2017

734-742

1 reference

Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study

12 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01456.X

Use of genomics and combinatorial chemistry in the development of new antimycobacterial drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01456.X

Tuberculosis in prisons in countries with high prevalence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01456.X

The growing burden of tuberculosis: global trends and interactions with the HIV epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01456.X

Tuberculosis epidemics driven by HIV: is prevention better than cure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01456.X

Tuberculosis recurrence in Africa: true relapse or re-infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01456.X

Prospects for worldwide tuberculosis control under the WHO DOTS strategy. Directly observed short-course therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01456.X

Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01456.X

The impact of human immunodeficiency virus on mortality of patients treated for tuberculosis in a cohort study in Zambia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01456.X

Scale up: meeting targets in global tuberculosis control

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01456.X

Effect of post-treatment isoniazid on prevention of recurrent tuberculosis in HIV-1-infected individuals: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01456.X

Malabsorption of rifampin and isoniazid in HIV-infected patients with and without tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01456.X

Tuberculosis programme changes and treatment outcomes in patients with smear-positive pulmonary tuberculosis in Blantyre, Malawi

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01456.X

Deaths from tuberculosis in sub-Saharan African countries with a high prevalence of HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01456.X

Preventing antiretroviral anarchy in sub-Saharan Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01456.X

Expanding antiretroviral therapy in Malawi: drawing on the country's experience with tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01456.X

Increased recurrence of tuberculosis in HIV-1-infected patients in Kenya.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01456.X

Two 8-month regimens of chemotherapy for treatment of newly diagnosed pulmonary tuberculosis: international multicentre randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01456.X

Effects of human immunodeficiency virus infection on recurrence of tuberculosis after rifampin-based treatment: an analytical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01456.X

Global health improvement and WHO: shaping the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01456.X

High AIDS awareness may cause tuberculosis patient delay: results from an HIV epidemic area, Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01456.X

The effect of human immunodeficiency virus type-1 on the infectiousness of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01456.X

Randomised trial of thiacetazone and rifampicin-containing regimens for pulmonary tuberculosis in HIV-infected Ugandans. The Makerere University-Case Western University Research Collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01456.X

Increased mortality and tuberculosis treatment failure rate among human immunodeficiency virus (HIV) seropositive compared with HIV seronegative patients with pulmonary tuberculosis treated with "standard" chemotherapy in Kinshasa, Zaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01456.X

HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01456.X

10.1111/J.1365-3156.2005.01456.X

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference

PubMed ID

16045459